Visolyr Information

Visolyr® is a clinical AI platform designed to improve cardiometabolic care. The signals of early disease progression sit scattered across disconnected EMRs, labs, imaging, medication records and social determinants of health. Visolyr brings them together to help clinicians navigate moments that matter. KAIROS™, our clinician-facing platform, orchestrates multiple AI models through iterative clinical reasoning. It turns unstructured, longitudinal and multimodal patient data into real-time, evidence-based intelligence designed for early detection, diagnostic support and personalized treatment recommendations. Our focus is rural and underserved communities, where specialist access is limited and KAIROS runs on the systems clinics already have. Beneath KAIROS sits ORCHID™, the orchestration layer. Two rules hold without exception: every model call routes through ORCHID, and every output is routed for clinician review. ORCHID is designed around four governance pillars. Provenance: every output is designed to trace back to its source data and permissions, for auditability. Validation: subgroup analysis and bias checks are designed to catch failures before they reach patients. Monitoring: continuous drift detection and performance telemetry are designed to prevent model decay. Human oversight: a clinician reviews every output and overrides are logged, so diagnostic authority stays with the care team. KAIROS and ORCHID together form Agentic Adaptive Intelligence™, Visolyr's framework for turning fragmented patient data into intelligence clinicians can independently review and apply.